Bioneer has extensive experience with stem cell biology in general and offers services that can assists clients in their discovery/research -and preclinical phase of stem cell product development. Bioneer is involved in several large collaboration projects, involving leading public institutions, related to cutting edge stem cell technologies.
Flow cytometry-based analyses of intracellular and surface biomarkers on MSC (mesenchymal stem cells, ESC (embryonic stem cells), iPSC (induced pluripotent stem cells) and HSC (hematopoietic stem cells).
Characterization of differentiation pathways of stem cells or progenitor cells using technology.
Determination of the effect of drugs or contact with matrices (medical devices) on the differentiation of stem cells into specific cell types.
Mobilization of stem cells from the bone marrow to the blood and subsequently to the injured tissue is a crucial process in tissue regeneration. Bioneer is able to evaluate the mobilization potential of drug candidates with our AP48 systems.
For further information, please contact Group Leader, Mammalian Cell Technology; Christian Clausen by phone (+45 45160444) or email.